Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Clinical Outcome
8 results:

  • 1. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
    Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. colorectal adenosquamous carcinoma: Peculiar morphologic features and distinct immunoprofiles in squamous and glandular components.
    Parente P; Mastracci L; Vanoli A; Businello G; Paudice M; Angerilli V; Castelvetere M; Graziano P; Fassan M; Grillo F
    Pathol Res Pract; 2022 Aug; 236():153967. PubMed ID: 35662040
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cdx2 Loss With Microsatellite Stable Phenotype Predicts Poor clinical outcome in Stage II colorectal Carcinoma.
    Slik K; Turkki R; Carpén O; Kurki S; Korkeila E; Sundström J; Pellinen T
    Am J Surg Pathol; 2019 Nov; 43(11):1473-1482. PubMed ID: 31490234
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Study of histopathologic parameters to define the prognosis of stage II colon cancer.
    Romiti A; Roberto M; Marchetti P; Di Cerbo A; Falcone R; Campisi G; Ferri M; Balducci G; Ramacciato G; Ruco L; Pilozzi E
    Int J Colorectal Dis; 2019 May; 34(5):905-913. PubMed ID: 30915540
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Methylation of cdx2 as a Predictor in Poor clinical outcome of Patients with colorectal cancer.
    Jiang G; Luo C; Sun M; Zhao Z; Li W; Chen K; Fan T
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):710-714. PubMed ID: 27754705
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma.
    Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Relationship of cdx2 loss with molecular features and prognosis in colorectal cancer.
    Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of the Cdx1 and cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells.
    Mallo GV; Soubeyran P; Lissitzky JC; André F; Farnarier C; Marvaldi J; Dagorn JC; Iovanna JL
    J Biol Chem; 1998 May; 273(22):14030-6. PubMed ID: 9593754
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.